FDA Weighs OTC Approval Of Singulair

WASHINGTON (AP) — Federal health regulators are weighing the risks of permitting Merck to sell its prescription respiratory pill, Singulair, as an over-the-counter medicine for allergies.
In a review posted online Wednesday, the Food and Drug Administration raised concerns that the…
Source:FDA Weighs OTC Approval Of Singulair